常规与选择性胺剂的管理,以减少TAVI后的出血: POPular ACE TAVI试验的理由和设计
Daniël C Overduin1, Dirk Jan van Ginkel1, Christophe Dubois2
1Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.
American heart journal
|November 2, 2025
概括
这项试验调查了透气管大动脉植入术 (TAVI) 后的常规蛋白质胺是否会降低死亡率或出血. 结果将澄清蛋白质胺的含量.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 临床试验 临床试验
背景情况:
- 在跨导管大动脉植入 (TAVI) 过程中,未分离的氨酸是标准的,以防止凝块.
- 胺硫酸盐可以逆转肝素,但具有过敏反应等风险.
- 有限的数据存在于TAVI后的Protamine的常规使用.
研究的目的:
- 评估TAVI后的常规胺剂的使用是否会降低全因死亡率或临床相关出血.
- 为了比较TAVI患者的常规与选择性前胺使用.
主要方法:
- 大众ACE TAVI试验是一项多中心,双盲,安慰剂对照的随机临床试验.
- 1000名患者将被随机分配到常规或选择性前胺的管理.
- 主要结局:综合所有原因死亡率和TAVI后30天内临床相关出血,根据VARC-3标准.
主要成果:
- 该研究正在进行中,招聘将于2023年11月开始.
- 主要和次要结果是根据VARC-3标准定义的.
- 安全结果包括过敏反应和血栓塞栓事件.
结论:
- 流行ACE TAVI试验 (NCT05774691) 将提供TAVI后对质氨酸使用的关键数据.
- 这些发现将指导临床实践,以确定常规与选择性前胺的管理.
相关概念视频
Venous Thrombosis III: Interprofessional Care
273
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
273
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
1.2K
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
1.2K


